MRCP2-2610

As an infectious disease expert with the World Health Organisation, I am faced with the challenge of updating guidelines on the first line treatment of severe malaria. However, there is a division of expert opinion regarding the recommendation of a new drug. In this scenario, what type of study would be appropriate for me to undertake?